(Q34547922)

2 August 2017

1 reference

title

Modern chemotherapeutic options for malaria (English)

1 reference

2 August 2017

0 references

1 reference

P Winstanley

1

1 reference

2 August 2017

publication date

1 November 2001

1 reference

Lancet Infectious Diseases

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

242-250

1 reference

An analysis of anemia and pregnancy-related maternal mortality

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

Impact of chloroquine resistance on malaria mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

An integrated assessment of the clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drug

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

4-Aminoquinolines--past, present, and future: a chemical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

Mechanism of cardiotoxicity of halofantrine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

Potentiation of halofantrine-induced QTc prolongation by mefloquine: correlation with blood concentrations of halofantrine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

CNS adverse events associated with antimalarial agents. Fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

The effects of mefloquine treatment in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

Lack of a significant adverse cardiovascular effect of combined quinine and mefloquine therapy for uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

Averting a malaria disaster

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

A new global commitment to disease control in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

A political analysis of corporate drug donations: the example of Malarone in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900119-0

7 January 2021

10.1016/S1473-3099(01)00119-0

Identifiers

DOI

1 reference

2 August 2017

1 reference